EMD SERONO

Neurology & Immunology
Endocrinology
Reproductive Health
Oncology
Rare Diseases

 

PrPIMJETMI®

 (pimicotinib)

 Capsules

  • 25mg

Professed Standard Therapeutic Classification: Kinase Inhibitor

Product Labeling

PrPIMJETMI® Product Monograph

pdf (644.6 kB)
View
Download

Educational Materials

Healthcare Professional Guide for
PrPIMJETMI® (pimicotinib capsules)

pdf (175.8 kB)
View
Download

Patient Educational Material
PrPIMJETMI® (pimicotinib capsules) 

pdf (135.3 kB)
View
Download

© EMD Inc. This site is intended for medical and scientific professionals only.

DISCLAIMER: This site and the information it contains is intended for residents of Canada only and is not medical advice. Contact a qualified physician or health care provider in your region if you have medical questions. Residents of the United States should consult www.emdserono.com for information on products and services approved in the U.S. If you do not agree to our Legal Statement and Privacy Policy, do not use this site. See our contact page for other ways to contact us.

EMD Serono is the healthcare business of Merck KGaA, Darmstadt, Germany in Canada and the United States.

CA-MAV-00264

 

MEDICAL RESOURCES / RESSOURCES MÉDICALES

This website is intended for healthcare professionals based in Canada. Are you a Canada-based healthcare professional?

Ce site internet s’adresse aux professionnels de la santé basés au Canada. Veuillez confirmer que vous êtes un professionnel de la santé basé au Canada.

Yes / Oui

No / Non